Clinical trial Recruiting at 1 site Interventional Ages 40 to 70

Kaltenborn versus Mulligan mobilization for wrist stiffness after Colles fracture

Official title: Comparison of Kaltenborn Mobilization and Mobilization With Movement (MWM) in Wrist Hypomobility After Colle's Fracture

Run by Foundation University Islamabad · NCT07060430 · Data updated 2026-11-12

This trial will try to see if Kaltenborn mobilization or Mulligan Mobilization with Movement helps adults aged 40–70 regain wrist motion after a Colles fracture treated in a cast.

More Colles Fracture trials

Quick facts

Study typeInterventional
Ages40 Years to 70 Years
SexAll
Enrollment40 (estimated)
SponsorFoundation University Islamabad
Academic / other
Locations1 site (Islamabad)
StatusRecruiting
StartedSeptember 15, 2024
Main results expectedJune 30, 2025
Study endsJune 30, 2025
Registry record updatedJuly 11, 2025
Trial IDNCT07060430 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 40–70 years old with persistent wrist stiffness after a Colles fracture that was treated conservatively with a plaster cast.

Probably not a fit

Patients who had surgical fixation (K‑wiring or ORIF), active neuromuscular disease, rheumatoid arthritis, metacarpal fractures, compartment syndrome, or non‑union are excluded and unlikely to benefit from these specific interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial assigns patients by coin toss to receive either Kaltenborn mobilization or Mulligan Mobilization with Movement for wrist hypomobility following a conservatively treated Colles fracture. Treatment includes joint mobilizations plus wrist, forearm, and finger range-of-motion and isometric exercises, as well as progressive hand-grip strengthening. Outcomes include changes in wrist, forearm and finger ROM, grip strength, and subjective stiffness. The trial enrolls adults 40–70 years old treated with plaster cast fixation, excludes those with surgical fixation or major comorbid musculoskeletal or neuromuscular conditions, and is conducted at Foundation University College of Physical Therapy in Islamabad.

Why it matters

Potential benefit: If successful, the trial could identify which manual therapy approach better reduces stiffness and improves wrist motion and grip strength after a Colles fracture.

How similar studies have gone: Previous small trials and physiotherapy reports suggest Mulligan and other manual mobilization techniques can help peripheral joint stiffness, but high-quality head-to-head comparisons at the wrist are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Both male and female participants (40-70 years old) Participants who will have diagnosed Colle's fracture and treated conservatively by plaster cast fixation and should referred from department of orthopedic surgery Patients group with post Colle's fractures stiffness

Exclusion Criteria:

* Patients having diagnosed Colle's fracture and treated with invasive procedure like K wiring, ORIF etc.

  * Patient with Neuromuscular injuries.(diagnosed)
  * Rheumatoid arthritis.
  * Patients with metacarpal fracture or compartment syndrome, non-union.(diagnosed)

Where it's running

  • Foundation University College of Physical Therapy
    Islamabad, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.